FundedIQ
Biotechnology

CoreMap: Funding, Investors & Team (Nov 2026)

CoreMap exists to improve patient outcomes by delivering advanced diagnostic technology to electrophysiologists and patients.

coremapmedical.com LinkedIn Burlington, United States 11-50 employees Founded 2016
Total raised
$67.5M
Rounds
3
Latest
Series C
Jul 2026

CoreMap has raised $67.5M across 3 funding rounds on record, the most recent a Series C of $37.0M announced in Jul 2026.

That round is above the $8.8M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

CoreMap Company Profile and Key Stats

Total funding raised
$67.5M
across 3 rounds on record
Funding rounds on record
3
Latest funding round
Series C
$37.0M in Jul 2026
Employees
11-50
reported band
Founded
2016
Headquarters
Burlington, United States
Investors on record
6
5 named below

Latest funding round on record: Jul 2026.

CoreMap Funding Rounds

Date
Round
Amount
Series C
$37.0M
Series B
$20.0M
Undisclosed round
$10.5M

CoreMap raised $10.5M in an undisclosed round announced in Sep 2020.

1.4 years later, a Series B of $20.0M was announced in Feb 2022.

4.4 years later, a Series C of $37.0M was announced in Jul 2026.

CoreMap Investors

National Science Foundation Medtronic Minnow Ventures Qure Ventures Russ Scully

6 investors are recorded in total; the 5 named above are those the record identifies.

CoreMap Founders and Leadership Team

Name
Role
Contact
Selin D
Founder
Locked
Sarah Kalil
CEO
Locked
Steven Berlin
CEO
Locked

Contact details for the CoreMap team: 3 of 3 have an email address on file, 2 have a LinkedIn profile.

Start 14-day free trial →

CoreMap Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,188
$8.8M
30,541
$7.8M
1,906
$60M

CoreMap's latest round of $37.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like CoreMap in Biotechnology and Burlington

Companies Similar to CoreMap

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus…

Series B $41.9M

Zafrens, a pharmaceutical research organization, focuses on designing life sciences solutions for…

Series A $6.0M

Quanta is a biotechnology company uncovering novel cancer therapeutic candidates to target driver oncogenes.…

Series D —

Arctic Therapeutics specializes in finding the genetic origins of common diseases and creating successful…

Undisclosed round $21.5M

100XBIO is creating a cutting-edge platform for analyzing multiple T-cells automatically, aiming to…

Pre-Seed $110k

MEND is a company focused on life sciences, determined to assist individuals in achieving better health…

Undisclosed round $1.5M

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

CoreMap Funding FAQs

What does CoreMap do?

CoreMap exists to improve patient outcomes by delivering advanced diagnostic technology to electrophysiologists and patients.

How much funding has CoreMap raised?

CoreMap has raised $67.5M across 3 rounds on record. The most recent is a Series C of $37.0M announced in Jul 2026.

When did CoreMap last raise funding?

CoreMap's most recent funding round on record is a Series C of $37.0M, announced in Jul 2026.

Who has invested in CoreMap?

Investors on record for CoreMap include National Science Foundation, Medtronic, Minnow Ventures, Qure Ventures, Russ Scully. FundedIQ records 6 investors in total.

Who founded CoreMap?

FundedIQ lists Selin D (Founder) at CoreMap.

Who is the CEO of CoreMap?

Sarah Kalil is listed as CEO at CoreMap.

Where is CoreMap headquartered?

CoreMap is based in Burlington, Massachusetts, United States.

How many employees does CoreMap have?

CoreMap is in the 11-50 employee band.

When was CoreMap founded?

CoreMap was founded in 2016.

How does CoreMap's funding compare to other Biotechnology startups?

CoreMap's latest round of $37.0M is above the $8.8M median round size for Biotechnology companies on FundedIQ across 4,188 tracked companies over the last two years.

About FundedIQ's CoreMap Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CoreMap is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.